The active chemical in psylocibe cubensis (the "magic mushrooms" shown here) is being studied closely for its potential therapeutic benefits. labuda/Getty Images hide caption toggle caption labuda/Getty Images Short Wave Brain Scientists Are Tripping Out Over Psychedelics December 21, 2022 Psychedelic drugs – like LSD, salvia, ayahuasca, Ibogaine, MDMA (AKA ecstasy), or psilocybin (AKA 'magic mushrooms' or 'shrooms') – are experiencing a resurgence of interest in their potential medical benefits. Brain Scientists Are Tripping Out Over Psychedelics Listen · 11:05 11:05 Transcript Toggle more options Download Embed Embed <iframe src="https://www.npr.org/player/embed/1144306776/1200393278" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player"> Transcript
Brain Scientists Are Tripping Out Over Psychedelics Listen · 11:05 11:05 Transcript Toggle more options Download Embed Embed <iframe src="https://www.npr.org/player/embed/1144306776/1200393278" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player"> Transcript